These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 12239593
1. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Nakatani T, Naganuma T, Masuda C, Uchida J, Sugimura T, Sugimura K. Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593 [Abstract] [Full Text] [Related]
2. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis. Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY. Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992 [Abstract] [Full Text] [Related]
3. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment]. Rasić S, Hadzovic-Dzuvo A, Rebić D, Dzemidzić J, Bilal F, Mataradzija A. Acta Med Croatica; 2008 Jul; 62 Suppl 1():7-11. PubMed ID: 18578326 [Abstract] [Full Text] [Related]
4. Relationships between brain natriuretic peptide, troponin I and QT dispersion in asymptomatic dialysis patients. Taskapan MC, Taskapan H, Ulutas O, Orhan M, Sahin I. Ren Fail; 2007 Jul; 29(2):221-5. PubMed ID: 17365940 [Abstract] [Full Text] [Related]
5. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction. Odar-Cederlöf I, Bjellerup P, Williams A, Blagg CR, Twardowski Z, Ting G, Kjellstrand CM. Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518 [Abstract] [Full Text] [Related]
7. [Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients]. Shao YH, Lai YQ, Lin AZ, Kong YZ. Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):892-4. PubMed ID: 16027094 [Abstract] [Full Text] [Related]
9. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients. Ludka O, Spinar J, Tomandl J, Konecny T. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):325-30. PubMed ID: 23154540 [Abstract] [Full Text] [Related]
10. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M. Int J Cardiol; 2005 Sep 15; 104(1):39-45. PubMed ID: 16137508 [Abstract] [Full Text] [Related]
11. Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients. Nishimura M, Hashimoto T, Kobayashi H, Fukukda T, Okino K, Yamamoto N, Nakamura N, Yoshikawa T, Takahashi H, Ono T. J Nephrol; 2003 Sep 15; 16(5):641-9. PubMed ID: 14733409 [Abstract] [Full Text] [Related]
12. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance. Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV. J Heart Lung Transplant; 2007 May 15; 26(5):516-21. PubMed ID: 17449423 [Abstract] [Full Text] [Related]
13. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Law YM, Ettedgui J, Beerman L, Maisel A, Tofovic S. Am J Cardiol; 2006 Aug 15; 98(4):520-4. PubMed ID: 16893709 [Abstract] [Full Text] [Related]
14. Significance of plasma B-type natriuretic peptide in hemodialysis patients: blood sample timing and comorbidity burden. Biasioli S, Zamperetti M, Borin D, Guidi G, De Fanti E, Schiavon R. ASAIO J; 2007 Aug 15; 53(5):587-91. PubMed ID: 17885332 [Abstract] [Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR. Am J Cardiol; 2006 May 15; 97(10):1530-4. PubMed ID: 16679099 [Abstract] [Full Text] [Related]
16. Adiponectin is associated with brain natriuretic peptide and left ventricular hypertrophy in hemodialysis patients with type 2 diabetes mellitus. Komaba H, Igaki N, Goto S, Yokota K, Takemoto T, Hirosue Y, Goto T. Nephron Clin Pract; 2007 May 15; 107(3):c103-8. PubMed ID: 17890872 [Abstract] [Full Text] [Related]
17. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET. Perit Dial Int; 2006 May 15; 26(3):360-5. PubMed ID: 16722030 [Abstract] [Full Text] [Related]
18. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE. J Am Soc Nephrol; 2007 Jan 15; 18(1):321-30. PubMed ID: 17167121 [Abstract] [Full Text] [Related]
19. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Sheen V, Bhalla V, Tulua-Tata A, Bhalla MA, Weiss D, Chiu A, Abdeen O, Mullaney S, Maisel A. Am Heart J; 2007 Feb 15; 153(2):244.e1-5. PubMed ID: 17239684 [Abstract] [Full Text] [Related]
20. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield SW, Towbin JA, Dreyer WJ. Circulation; 2006 Sep 05; 114(10):1063-9. PubMed ID: 16940194 [Abstract] [Full Text] [Related] Page: [Next] [New Search]